Equity

Company Snapshot Home > Equity > Corporate Information > Company Snapshot

Novartis India LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500672 P/E (TTM) :18.04
ISIN Demat:INE234A01025 Div & Yield %:3.21 EPS (TTM) :43.17
Book Value (RS) :313.912669 Market Cap (Rs Cr.):1923.41 Face Value (RS) :5
    Change Company 
Stock Price Details Chart
Last Price (RS) 782.90 
Change (%) 3.90 (0.50%) 
Best Buy (RS) 778.1(x3) 
Best Sell (RS) 782.9(x41) 
Today's Range (RS) 775.20 - 783.90 
52-Week Range (RS) 744.95 - 1,099.90 
Beta (1 Year) 0.51 
| | | |
Index Details
BSE HC, BSE SmallCap
News Corporate Details
Novartis India to table results
Novartis India standalone net profit rises 18.67% in the September 2025 quarter
Novartis India to conduct board meeting
Novartis India Ltd - Closure of Trading Window
Novartis India Ltd - Board Meeting Intimation for Inter Alia Considering The Unaudited Financial Results For The Half Ye...
Novartis India Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
Novartis India standalone net profit rises 7.30% in the June 2025 quarter
Novartis India Ltd - Board Meeting Outcome for Intimation About The Outcome Of The Board Meeting Held On July 29 2025 In...
Novartis India Ltd - Unaudited Financial Results For The Quarter Ended As On June 30 2025.
Novartis India Ltd - Announcement under Regulation 30 (LODR)-Change in Management
Incoporation Year :  1947
Chairman : C Snook
Ownership Group : MNC Associate
Sector : MAN
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
Registered Office
Novartis India Ltd
The Inspire BKC Part 601 & 701,
Bandra Kurla Complex Bandra(E),
Mumbai,
Maharashtra-400051
Phone:91-022-50243000
Fax:91-022-50243010
E-Mail : india.investors@novartis.com
URL : http://www.novartis.in
Investor Returns
  Date Price Returns (%)
1Week 24-Dec-2025 787.25 -1.05
1Month 01-Dec-2025 810.95 -3.94
3Month 30-Sep-2025 875.25 -11.00
6Month 30-Jun-2025 1051.90 -25.94
1Year 31-Dec-2024 919.80 -15.31
Mutual Funds Holding
Scheme Name % Holding Market Value (Rs Cr.)
Motilal Oswal BSE Healthcare ETF 0.04 0.02
Bandhan BSE Healthcare Index Fund 0.04 0.01
Motilal Oswal BSE 1000 Index Fund 0.00 0.00
Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln
Company Last Price Change (%) 52Week High 52Week Low Market Cap (Rs Cr.)
Sun Pharmaceutical Industries Ltd 1,714.05 -0.33 1,910.00 1,547.25 412,625.63
Cipla Ltd 1,504.00 -0.46 1,672.20 1,310.05 122,046.15
Dr Reddys Laboratories Ltd 1,254.85 -1.27 1,404.60 1,025.90 106,085.69
Lupin Ltd 2,094.25 -0.84 2,403.45 1,774.00 96,475.91
Zydus Lifesciences Ltd 910.50 -0.45 1,059.00 797.05 92,035.19

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)